Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pulmotone Vet is a veterinary oral solution and spray formulation composed of a 30% blend of essential oils and plant extracts, including eucalyptus, peppermint, carvacrol, thyme, and camphor. Developed and marketed by Navana Pharmaceuticals and manufactured by Montajat Veterinary Pharmaceuticals, it is indicated for relieving respiratory distress and symptoms associated with infections (such as chronic respiratory disease, mycoplasmosis, coryza, bronchitis, and brooder pneumonia) in poultry, horses, and cattle. It is also used to reduce respiratory reactions following live vaccinations and to ease breathing during environmental stressors like elevated ammonia levels, extreme temperatures, or litter transfer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pulmotone Vet.